Secret Site Map
Friday, October 31, 2014

Home News FDA Approves First Scorpion Sting Antidote

FDA Approves First Scorpion Sting Antidote

Stinging Insects

The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

| January 6, 2012

WASHINGTON - The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

Venomous scorpions in the U.S. are mostly found in Arizona. Severe stings occur most frequently in infants and children, and can cause shortness of breath, fluid in the lungs, breathing problems, excess saliva, blurred vision, slurred speech, trouble swallowing, abnormal eye movements, muscle twitching, trouble walking, and other uncoordinated muscle movements. Untreated cases can be fatal.

“This product provides a new treatment for children and adults and is designed specifically for scorpion stings,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research. “Scorpion stings can be life-threatening, especially in infants and children.”

Anascorp, Centruroides (Scorpion) Immune F(ab’)2 (Equine) Injection, is made from the plasma of  horses immunized with scorpion venom. Anascorp may cause early or delayed allergic reactions in people sensitive to horse proteins. The manufacturing process for

Anascorp includes steps to decrease the chance of allergic reactions and to reduce the risk of transmission of viruses that may be present in the plasma.

The effectiveness of Anascorp was based on results from a randomized, double-blind, placebo-controlled trial of 15 children with neurological signs of scorpion stings. These signs resolved within four hours of treatment in the eight subjects who received

Top news

Three Industry Leaders Recognized at Univar International Reception

Univar Director Latin America Benjamin Gomez recognized three industry leaders at PestWorld’s International Reception, including Norm Cooper, recognized with the Global Ambassador Lifetime Achievement Award.

UPFDA Recognizes Contributions of Tommy Reeves at Board Meeting

Reeves recently completed a two-year term as UPFDA president where he was instrumental in establishing the future direction of the association.

Cope Named Director of Technical and Regulatory Services at Terminix

Dr. Stan Cope (retired Navy), who has been with Terminix since 2012, has been promoted.

P+L Systems Announces Acquisition

Group De Ceuster of Sint-Katelijne-Waver, Belgium announced the sale of its Environmental Care division to P+L Systems (Holding) UK of Knaresborough, UK, for an undisclosed sum.

Backed By Bayer Web Portal Relaunched

New Backed By Bayer is a a comprehensive customer-centric platform with new and expanded resources for pest management professionals.

x